Vanessa Moll MD, PhD Named CMO of Potrero Medical
Dr. Moll brings 20 years of clinical and research experience to the company. She is a board-certified anesthesiologist and intensivist and has worked both in the US and European healthcare systems.
Gregory D. Casciaro Appointed to Colospan’s Board
Mr. Casciaro has served in numerous executive leadership roles in the medtech industry, most recently as the President and CEO of Cardiac Dimension and prior to that as the CEO of AccessClosure
Clinical Experts Establish 1st Ever Global Consensus for the Appropriate Use of IVUS in Peripheral Vascular Disease Interventions
The new consensus and recommendations for use of IVUS aim to improve quality care in PVD and are based on evidence, expert practice standards, and clinical experience.
Gynesonics Announces First Office-Based Sonata Treatment Procedure in the State of Texas
Sonata Treatment is a breakthrough alternative to hysterectomy & myomectomy, & can treat a wider range of fibroid types, sizes, & locations than hysteroscopic myomectomy.
MicroPort Orthopedics Welcomes C. Lowry Barnes, M.D. to Leadership Team as Medical Director
In his new and expanded role as Medical Director, Dr. Barnes will play a key role in the strategic decision-making and vision of the company, including medical education and training, clinical research, product development, surgeon relations, and same-day surgical procedures around the world.